Brian Corvese - Net Worth and Insider Trading

Brian Corvese Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Brian Corvese owns 3 companies in total, including Agenus Inc (AGEN) , Protagenic Therapeutics Inc (PTIX) , and MiNK Therapeutics Inc (INKT) .

Click here to see the complete history of Brian Corvese’s form 4 insider trades.

Insider Ownership Summary of Brian Corvese

Ticker	Comapny	Transaction Date	Type of Owner
AGEN	Agenus Inc	2018-03-31	director
PTIX	Protagenic Therapeutics Inc	2017-10-16	director
INKT	MiNK Therapeutics Inc	2021-10-13	director

Brian Corvese Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Brian Corvese Ownership Network

Ownership Network List of Brian Corvese

No Data

Ownership Network Relation of Brian Corvese

Brian Corvese Owned Company Details

What does Agenus Inc do?

Who are the key executives at Agenus Inc?

Brian Corvese is the director of Agenus Inc. Other key executives at Agenus Inc include Chairman & CEO Garo H Armen , Chief Medical Officer Steven J O'day , and VP Finance Christine M Klaskin .

Agenus Inc (AGEN) Insider Trades Summary

Over the past 18 months, Brian Corvese made no insider transaction in Agenus Inc (AGEN). Other recent insider transactions involving Agenus Inc (AGEN) include a net purchase of 500,000 shares made by Garo H Armen , and a net purchase of 25,000 shares made by Ulf Wiinberg .

In summary, during the past 3 months, insiders sold 0 shares of Agenus Inc (AGEN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Agenus Inc (AGEN) were sold and 26,250 shares were bought by its insiders, resulting in a net purchase of 26,250 shares.

Agenus Inc (AGEN)'s detailed insider trading history can be found in Insider Trading Tracker table.

Agenus Inc Insider Transactions

No Available Data

What does Protagenic Therapeutics Inc do?

Who are the key executives at Protagenic Therapeutics Inc?

Brian Corvese is the director of Protagenic Therapeutics Inc. Other key executives at Protagenic Therapeutics Inc include Chief Financial Officer Alexander K. Arrow , director & 10 percent owner & See Remarks Garo H Armen , and COO / Interim President Robert Ziroyan .

Protagenic Therapeutics Inc (PTIX) Insider Trades Summary

Over the past 18 months, Brian Corvese made no insider transaction in Protagenic Therapeutics Inc (PTIX). Other recent insider transactions involving Protagenic Therapeutics Inc (PTIX) include a net purchase of 8,000 shares made by Alexander K. Arrow ,

In summary, during the past 3 months, insiders sold 0 shares of Protagenic Therapeutics Inc (PTIX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Protagenic Therapeutics Inc (PTIX) were sold and 8,000 shares were bought by its insiders, resulting in a net purchase of 8,000 shares.

Protagenic Therapeutics Inc (PTIX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Protagenic Therapeutics Inc Insider Transactions

No Available Data

What does MiNK Therapeutics Inc do?

Who are the key executives at MiNK Therapeutics Inc?

Brian Corvese is the director of MiNK Therapeutics Inc. Other key executives at MiNK Therapeutics Inc include 10 percent owner Agenus Inc , Treasurer Christine M Klaskin , and director & See Remarks Jennifer Buell .

MiNK Therapeutics Inc (INKT) Insider Trades Summary

Over the past 18 months, Brian Corvese made no insider transaction in MiNK Therapeutics Inc (INKT). Other recent insider transactions involving MiNK Therapeutics Inc (INKT) include a net purchase of 546,494 shares made by Agenus Inc , and a net sale of 0 shares made by Garo H Armen .

In summary, during the past 3 months, insiders sold 0 shares of MiNK Therapeutics Inc (INKT) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 100,000 shares of MiNK Therapeutics Inc (INKT) were sold and 646,494 shares were bought by its insiders, resulting in a net purchase of 546,494 shares.

MiNK Therapeutics Inc (INKT)'s detailed insider trading history can be found in Insider Trading Tracker table.

MiNK Therapeutics Inc Insider Transactions

No Available Data

Brian Corvese Mailing Address

Above is the net worth, insider trading, and ownership report for Brian Corvese. You might contact Brian Corvese via mailing address: C/o Antigenics Inc., 162 Fifth Avenue, Suite 900, New York Ny 10010.

Discussions on Brian Corvese

No discussions yet.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us ETF Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.